[Insulin autoimmune syndrome].
Wasada
Taro
T
Department of Internal Medicine (Diabetology), Saitama-ken Saiseikai Kurihashi Hospital.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000009:adverse effects / Q000737:chemistry; D001327:Autoimmune Diseases / Q000209:etiology; D050528:Diet, Carbohydrate-Restricted; D005838:Genotype; D006680:HLA Antigens / Q000235:genetics; D006650:Histocompatibility Testing; D006801:Humans; D007003:Hypoglycemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007328:Insulin / Q000276:immunology*; D007330:Insulin Antibodies / Q000276:immunology*; D008713:Methimazole / Q000009:adverse effects / Q000737:chemistry; D013438:Sulfhydryl Compounds / Q000009:adverse effects; D013577:Syndrome
D000305:Adrenal Cortex Hormones; D013956:Antithyroid Agents; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007328:Insulin; D007330:Insulin Antibodies; D013438:Sulfhydryl Compounds; D008713:Methimazole